BRETEC — Bioretec Oy Income Statement
0.000.00%
Last trade - 00:00- €51.84m
- €48.32m
- €4.54m
Annual income statement for Bioretec Oy, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
| Standards: | FAS | FAS | FAS | FAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1.5 | 2 | 2.94 | 3.91 | 4.54 |
| Cost of Revenue | |||||
| Gross Profit | 1.1 | 1.38 | 2.14 | 2.73 | 3.22 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.42 | 4.67 | 5.23 | 6.94 | 8.75 |
| Operating Profit | -1.92 | -2.67 | -2.29 | -3.03 | -4.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.26 | -6.02 | -2.42 | -3.79 | -4.61 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.26 | -6.02 | -2.42 | -3.79 | -4.61 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.26 | -6.02 | -2.42 | -3.79 | -4.61 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.26 | -6.02 | -2.42 | -3.79 | -4.61 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.163 | -0.312 | -0.011 | -0.194 | -0.215 |
| Dividends per Share |